Description

4-((6-Bromo-4-Phenylquinazolin-2-Yl)Amino)-n-(4-Methoxyphenyl)Benzamide is a high-purity, advanced pharmaceutical intermediate belonging to the quinazoline class of heterocyclic compounds. This compound is critical for research and development in medicinal chemistry, particularly in the synthesis of targeted therapeutic agents. It is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing novel kinase inhibitors and other small-molecule drugs.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel drug candidates, particularly kinase inhibitors for oncology and inflammatory disease research.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization processes to develop new therapeutic molecules.
• Biochemical Tool Compound: Serves as a reference standard or a probe in biochemical assays to study specific enzyme interactions and pathways.
• Fine Chemical Synthesis: Employed in multi-step organic synthesis for creating complex, high-value specialty chemicals with specific biological activities.
• Academic Research: Utilized in university and institutional laboratories for cutting-edge research in organic synthesis and drug discovery methodologies.
• Contract Research & Manufacturing (CRO/CMO): Supplied to service organizations supporting the pharmaceutical industry's outsourced R&D and production needs.

Basic Information

Product Name	4-((6-Bromo-4-Phenylquinazolin-2-Yl)Amino)-n-(4-Methoxyphenyl)Benzamide
CAS No.	313398-13-9
Molecular Formula	C28H21BrN4O2
Molecular Weight	525.40 g/mol
Synonyms	4-[(6-Bromo-4-phenylquinazolin-2-yl)amino]-N-(4-methoxyphenyl)benzamide; 4-((6-Bromo-4-phenylquinazolin-2-yl)amino)-N-(4-methoxyphenyl)benzamide; Benzamide, 4-((6-bromo-4-phenyl-2-quinazolinyl)amino)-N-(4-methoxyphenyl)-; 313398-13-9; 4-[(6-Bromo-4-phenyl-2-quinazolinyl)amino]-N-(4-methoxyphenyl)benzamide; N-(4-Methoxyphenyl)-4-((6-bromo-4-phenylquinazolin-2-yl)amino)benzamide
EINECS	Contact for details

Quality Control

Our 4-((6-Bromo-4-Phenylquinazolin-2-Yl)Amino)-n-(4-Methoxyphenyl)Benzamide is manufactured under strict quality control protocols to ensure batch-to-batch consistency and high purity, meeting the stringent requirements of pharmaceutical R&D. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We adhere to relevant quality management standards to guarantee reliable supply and traceability for our global customers.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). The product is light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.